{"id":"https://openalex.org/W899728","doi":null,"title":"Pharmacokinetic drug interaction studies with candesartan cilexetil.","display_name":"Pharmacokinetic drug interaction studies with candesartan cilexetil.","publication_year":1997,"publication_date":"1997-09-01","ids":{"openalex":"https://openalex.org/W899728","mag":"899728","pmid":"https://pubmed.ncbi.nlm.nih.gov/9331003"},"language":"en","primary_location":{"id":"pmid:9331003","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9331003","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of human hypertension","raw_type":"Clinical Trial"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109583177","display_name":"J H Jonkman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J H Jonkman","raw_affiliation_strings":["Pharma Bio-Research International, Zuidlaren, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharma Bio-Research International, Zuidlaren, The Netherlands","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055811263","display_name":"Jan Jaap van Lier","orcid":"https://orcid.org/0000-0001-9676-5136","observed_orcids":["https://orcid.org/0000-0001-9676-5136"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J J van Lier","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110425206","display_name":"Pauline N. M. van Heiningen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P N van Heiningen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033324762","display_name":"Robert L. Lins","orcid":"https://orcid.org/0000-0001-9372-8073","observed_orcids":["https://orcid.org/0000-0001-9372-8073"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R Lins","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044499834","display_name":"Regina Sennewald","orcid":"https://orcid.org/0000-0002-6499-0942","observed_orcids":["https://orcid.org/0000-0002-6499-0942"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R Sennewald","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5060749837","display_name":"A. H\u00f6gemann","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A H\u00f6gemann","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.4348,"has_fulltext":false,"cited_by_count":19,"citation_normalized_percentile":{"value":0.77445514,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":93},"biblio":{"volume":"11 Suppl 2","issue":null,"first_page":"S31","last_page":"5"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.7113999724388123,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.7113999724388123,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.16500000655651093,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.03819999843835831,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/candesartan-cilexetil","display_name":"candesartan cilexetil","score":0.9990000128746033},{"id":"https://openalex.org/keywords/pharmacokinetic-interactions","display_name":"pharmacokinetic interactions","score":0.9079999923706055},{"id":"https://openalex.org/keywords/hydrochlorothiazide","display_name":"hydrochlorothiazide","score":0.9710000157356262},{"id":"https://openalex.org/keywords/nifedipine","display_name":"nifedipine","score":0.9929999709129333},{"id":"https://openalex.org/keywords/glibenclamide","display_name":"glibenclamide","score":0.9990000128746033},{"id":"https://openalex.org/keywords/warfarin","display_name":"warfarin","score":0.9940000176429749},{"id":"https://openalex.org/keywords/digoxin","display_name":"digoxin","score":1.0},{"id":"https://openalex.org/keywords/oral-contraceptives","display_name":"oral contraceptives","score":0.9850000143051147},{"id":"https://openalex.org/keywords/bioequivalence","display_name":"bioequivalence","score":0.8040000200271606},{"id":"https://openalex.org/keywords/bioavailability","display_name":"bioavailability","score":0.7870000004768372},{"id":"https://openalex.org/keywords/antihypertensive-drugs","display_name":"antihypertensive drugs","score":0.7279999852180481},{"id":"https://openalex.org/keywords/prodrugs","display_name":"prodrugs","score":0.3199999928474426}],"concepts":[{"id":"https://openalex.org/C2780036600","wikidata":"https://www.wikidata.org/wiki/Q415970","display_name":"Candesartan","level":4,"score":0.9801533222198486},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8316802978515625},{"id":"https://openalex.org/C2780361556","wikidata":"https://www.wikidata.org/wiki/Q423930","display_name":"Hydrochlorothiazide","level":3,"score":0.7968387603759766},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.7423295974731445},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6841440796852112},{"id":"https://openalex.org/C2777707475","wikidata":"https://www.wikidata.org/wiki/Q422222","display_name":"Digoxin","level":3,"score":0.5935372710227966},{"id":"https://openalex.org/C97320921","wikidata":"https://www.wikidata.org/wiki/Q718753","display_name":"Drug interaction","level":3,"score":0.5741893649101257},{"id":"https://openalex.org/C22979827","wikidata":"https://www.wikidata.org/wiki/Q5137311","display_name":"Cmax","level":3,"score":0.4778537452220917},{"id":"https://openalex.org/C42404028","wikidata":"https://www.wikidata.org/wiki/Q864940","display_name":"Bioequivalence","level":3,"score":0.46155428886413574},{"id":"https://openalex.org/C2777056448","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Oral administration","level":2,"score":0.4451693594455719},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.25141358375549316},{"id":"https://openalex.org/C2908929049","wikidata":"https://www.wikidata.org/wiki/Q65963433","display_name":"Angiotensin II","level":3,"score":0.15695896744728088},{"id":"https://openalex.org/C2778198053","wikidata":"https://www.wikidata.org/wiki/Q181754","display_name":"Heart failure","level":2,"score":0.07164037227630615},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.057012319564819336},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000959","descriptor_name":"Antihypertensive Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001562","descriptor_name":"Benzimidazoles","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D001562","descriptor_name":"Benzimidazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001713","descriptor_name":"Biphenyl Compounds","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D001713","descriptor_name":"Biphenyl Compounds","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D004077","descriptor_name":"Digoxin","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005905","descriptor_name":"Glyburide","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006852","descriptor_name":"Hydrochlorothiazide","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009543","descriptor_name":"Nifedipine","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D013777","descriptor_name":"Tetrazoles","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D014859","descriptor_name":"Warfarin","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D057911","descriptor_name":"Angiotensin Receptor Antagonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:9331003","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9331003","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of human hypertension","raw_type":"Clinical Trial"},{"id":"mag:899728","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9331003","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":13,"referenced_works":["https://openalex.org/W4232923566","https://openalex.org/W1792734134","https://openalex.org/W2065932303","https://openalex.org/W1979677898","https://openalex.org/W2015960666","https://openalex.org/W2001151576","https://openalex.org/W1966561815","https://openalex.org/W2011989937","https://openalex.org/W2113086633","https://openalex.org/W2081925327","https://openalex.org/W2005960977","https://openalex.org/W1976270201","https://openalex.org/W2313239865"],"related_works":["https://openalex.org/W2026666973","https://openalex.org/W2096242190","https://openalex.org/W2005701339","https://openalex.org/W2157789131","https://openalex.org/W3022380633","https://openalex.org/W2328445782","https://openalex.org/W2887302631","https://openalex.org/W2089698436","https://openalex.org/W2072116635","https://openalex.org/W2460103661"],"abstract_inverted_index":{"The":[0,66],"aim":[1],"of":[2,5,34,60,78,94,107,119,142,164,209],"this":[3,156,187],"series":[4],"studies":[6,40],"was":[7,55,213],"to":[8,192],"determine":[9],"the":[10,20,32,90,117,122,139,175,206,222],"potential":[11],"for":[12,71,127,130,180],"pharmacokinetic":[13,67,207],"interaction":[14],"between":[15],"candesartan":[16,22,75,104,108,135,165,181],"(administered":[17],"orally":[18,57],"as":[19],"prodrug":[21],"cilexetil)":[23],"and":[24,74,177,183,218],"hydrochlorothiazide":[25],"(HCTZ),":[26],"nifedipine,":[27,95],"glibenclamide,":[28,96,201],"warfarin,":[29],"digoxin":[30,97],"or":[31,49,63,82,98],"components":[33],"an":[35],"oral":[36,99,203],"contraceptive":[37],"formulation.":[38],"All":[39],"were":[41,69,86,137],"performed":[42],"in":[43,83,89,116,150,174,219],"healthy":[44],"volunteers":[45],"using":[46],"randomised,":[47],"crossover":[48],"add-on":[50],"study":[51],"designs.":[52],"Candesartan":[53,144,211],"cilexetil":[54,109,136,145,166,212],"administered":[56],"at":[58],"doses":[59],"8,":[61],"12":[62],"16":[64],"mg.":[65],"parameters":[68,208],"determined":[70],"comparator":[72],"agents":[73],"following":[76],"administration":[77],"each":[79],"agent":[80],"alone":[81,217],"combination.":[84],"There":[85],"no":[87,158],"changes":[88],"drug":[91,199],"plasma":[92,152],"concentrations":[93],"contraceptives":[100],"when":[101,132],"co-administered":[102,133,198],"with":[103,134,167,221],"cilexetil.":[105],"Co-administration":[106,163],"caused":[110],"a":[111,147,170],"slight":[112],"but":[113,155],"significant":[114,172],"decrease":[115,149],"AUC":[118,128],"HCTZ.":[120],"However,":[121,186],"90%":[123],"confidence":[124],"intervals":[125],"(CI)":[126],"ratios":[129],"HCTZ":[131,168],"within":[138],"defined":[140],"limits":[141],"bioequivalence.":[143],"produced":[146,169],"7%":[148],"trough":[151],"warfarin":[153],"concentration":[154],"had":[157],"effect":[159],"on":[160],"prothrombin":[161],"time.":[162],"statistically":[171],"increase":[173,188],"bioavailability":[176],"Cmax":[178],"values":[179],"(18%":[182],"25%,":[184],"respectively).":[185],"is":[189],"not":[190],"considered":[191],"be":[193],"clinically":[194],"relevant.":[195],"No":[196],"other":[197,223],"(nifedipine,":[200],"digoxin,":[202],"contraceptive)":[204],"affected":[205],"candesartan.":[210],"well":[214],"tolerated":[215],"both":[216],"combination":[220],"agents.":[224]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}